Celltrion
068270.KS
#761
Rank
C$38.60 B
Marketcap
$179.38
Share price
-0.28%
Change (1 day)
-1.44%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.34. In 2022 the company made an earnings per share (EPS) of $4.23 a decrease over its 2021 EPS that were of $5.02.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.04-4.52%
2022$4.23-15.84%
2021$5.0212.77%
2020$4.4570.79%
2019$2.6115.63%
2018$2.26-33.13%
2017$3.37141.17%
2016$1.408.28%
2015$1.2911.28%
2014$1.1616.37%
2013$1.00-67.42%
2012$3.0684.22%
2011$1.6662.13%
2010$1.0380.61%
2009$0.57-559.63%
2008-$0.12-123.16%
2007$0.53